Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors

по Pal, Sumanta Kumar, Figlin, Robert A.
Опубликовано 2010

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

по Pal, Sumanta Kumar, Figlin, Robert A.
Опубликовано 2011

A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted Therapy

по Banerjee, Natasha, Sachdev, Esha, Figlin, Robert A
Опубликовано в: Cureus (2016)

Deciphering the anticancer mechanisms of sunitinib

по Pal, Sumanta Kumar, Figlin, Robert A, Yu, Hua
Опубликовано 2010

Targeted Therapies for Non-Small Lung Cancer: An Evolving Landscape

по Pal, Sumanta Kumar, Figlin, Robert A., Reckamp, Karen
Опубликовано 2010

A New Age for Vaccine Therapy in Renal Cell Carcinoma

по Pal, Sumanta K., Hu, Adriana, Figlin, Robert A.
Опубликовано 2013

Renal cell carcinoma: An update for the practicing urologist

по Pal, Sumanta K., Bergerot, Paulo, Figlin, Robert A.
Опубликовано в: Asian J Urol (2015)

Gut microbiome, antibiotic use, and immunotherapy responsiveness in cancer

по Reed, Jarred P., Devkota, Suzanne, Figlin, Robert A.
Опубликовано в: Ann Transl Med (2019)

Renal cell carcinoma molecular targets and clinical applications, second edition /

по Bukowski, Ronald M., Figlin, Robert A., Motzer, Robert J.
Опубликовано 2009

Renal cell carcinoma translational biology, personalized medicine, and novel therapeutic targets /

по Figlin, Robert A., Rathmell, W. Kimryn., Rini, Brian I.
Опубликовано 2012

Chemokines as therapeutic targets in renal cell carcinoma

по Reckamp, Karen L, Strieter, Robert M, Figlin, Robert A
Опубликовано 2008

Tivozanib: Current status and future directions in the treatment of solid tumors

по Pal, Sumanta K., Bergerot, Paulo G., Figlin, Robert A.
Опубликовано 2012

Surveillance Strategies for Renal Cell Carcinoma Patients Following Nephrectomy

по Chin, Arnold I, Lam, John S, Figlin, Robert A, Belldegrun, Arie S
Опубликовано 2006

Akt inhibitors in clinical development for the treatment of cancer

по Kumar Pal, Sumanta, Reckamp, Karen, Yu, Hua, Figlin, Robert A.
Опубликовано 2010

Breaking through a plateau in renal cell carcinoma therapeutics: Development and incorporation of biomarkers

по Pal, Sumanta Kumar, Kortylewski, Marcin, Yu, Hua, Figlin, Robert A.
Опубликовано 2010

Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma

по Motzer, Robert J., Escudier, Bernard, Gannon, Andrew, Figlin, Robert A.
Опубликовано в: Oncologist (2016)

Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults

по Pal, Sumanta K., Vanderwalde, Ari, Hurria, Arti, Figlin, Robert A.
Опубликовано в: Drugs Aging (2011)

STAT3: A Target to Enhance Antitumor Immune Response

по Lee, Heehyoung, Pal, Sumanta Kumar, Reckamp, Karen, Figlin, Robert A., Yu, Hua
Опубликовано 2011

A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models

по Zhang, Hao, Berel, Dror, Wang, Yanping, Li, Ping, Bhowmick, Neil A., Figlin, Robert A., Kim, Hyung L.
Опубликовано 2013

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

по Reckamp, Karen L, Figlin, Robert A, Burdick, Marie D, Dubinett, Steven M, Elashoff, Robert M, Strieter, Robert M
Опубликовано 2009